Advertisement

Examining the True Prevalence of Hypercortisolism and Its Impact on Managing Resistant Diabetes - Episode 1

Overview of the CATALYST Study for Hypercortisolism

Published on: 
, , ,

The CATALYST study is discussed by a panel of experts led by Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCES.

Video content above is prompted by the following:

  • What is the significance of the CATALYST trial? Can you explain the rationale for the study?
Advertisement
Advertisement